Theravance Biopharma logo

Theravance Biopharma Share Price Today

(NASDAQ: TBPH)

Theravance Biopharma share price is $9.72 & ₹845.34 as on 6 Mar 2025, 2.30 'hrs' IST

$9.72

▲

0.62

(6.81%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Theravance Biopharma share price in Dollar and Rupees. Guide to invest in Theravance Biopharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Theravance Biopharma, along with analyst recommendations, forecasts, and comprehensive financials.

Theravance Biopharma share price movements

  • Today's Low: $9.08
    Today's High: $9.80

    Day's Volatility :7.4%

  • 52 Weeks Low: $7.44
    52 Weeks High: $10.90

    52 Weeks Volatility :31.74%

Theravance Biopharma (TBPH) Returns

PeriodTheravance Biopharma IncSector (Health Care)Index (Russel 2000)
3 Months
-1.22%
3.7%
0.0%
6 Months
18.97%
-2.8%
0.0%
1 Year
11.21%
2.5%
0.0%
3 Years
0.41%
12.9%
-11.6%

Theravance Biopharma (TBPH) Key Statistics

in dollars & INR

Previous Close
$9.1
Open
$9.14
Today's High
$9.8
Today's Low
$9.075
Market Capitalization
$450.5M
Today's Volume
$331.9K
52 Week High
$10.9
52 Week Low
$7.44
Revenue TTM
$64.4M
EBITDA
$-40.7M
Earnings Per Share (EPS)
$-1.14
Profit Margin
-87.63%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-29.04%

How to invest in Theravance Biopharma Stock (TBPH) from India?

It is very easy for Indian residents to invest directly in Theravance Biopharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Theravance Biopharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Theravance Biopharma or TBPH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Theravance Biopharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Theravance Biopharma shares which would translate to 0.089 fractional shares of Theravance Biopharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Theravance Biopharma, in just a few clicks!

Returns in Theravance Biopharma (TBPH) for Indian investors in Rupees

The Theravance Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Theravance Biopharma investment value today

Current value as on today

₹1,16,162

Returns

₹16,162

(+16.16%)

Returns from Theravance Biopharma Stock

₹11,213 (+11.21%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Theravance Biopharma (TBPH)

67%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Theravance Biopharma Stock from India on INDmoney has increased by 67% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Theravance Biopharma

  • Madison Avenue Partners, LP

    19.21%

  • Weiss Asset Management LP

    15.06%

  • Newtyn Management LLC

    9.61%

  • BlackRock Inc

    7.50%

  • Irenic Capital Management LP

    5.58%

  • Vanguard Group Inc

    4.06%

Analyst Recommendation on Theravance Biopharma

Buy

    72%Buy

    27%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Theravance Biopharma(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
7
7
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Theravance Biopharma Stock (TBPH)

What analysts predicted

Upside of 49.18%

Target:

$14.50

Current:

$9.72

Insights on Theravance Biopharma Stock (Ticker Symbol: TBPH)

  • Price Movement

    In the last 7 days, TBPH stock has moved up by 4.9%

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 14.25M → 16.86M (in $), with an average increase of 15.5% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -16.52M → -12.69M (in $), with an average increase of 30.2% per quarter

  • TBPH vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 55.3%

  • TBPH vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 50.5%

  • Price to Sales

    ForTBPH every $1 of sales, investors are willing to pay $7.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

TBPH Theravance Biopharma Financials in INR & Dollars

FY18Y/Y Change
Revenue
$60.4M
↑ 292.37%
Net Income
$-215.5M
↓ 24.48%
Net Profit Margin
-357.01%
↑ 1497.96%
FY19Y/Y Change
Revenue
$73.4M
↑ 21.61%
Net Income
$-236.5M
↑ 9.71%
Net Profit Margin
-322.08%
↑ 34.93%
FY20Y/Y Change
Revenue
$71.9M
↓ 2.12%
Net Income
$-278.0M
↑ 17.58%
Net Profit Margin
-386.9%
↓ 64.82%
FY21Y/Y Change
Revenue
$55.3M
↓ 23.03%
Net Income
$-199.4M
↓ 28.27%
Net Profit Margin
-360.55%
↑ 26.35%
FY22Y/Y Change
Revenue
$51.3M
↓ 7.17%
Net Income
$-92.8M
↓ 53.45%
Net Profit Margin
-180.78%
↑ 179.77%
FY23Y/Y Change
Revenue
$57.4M
↑ 11.84%
Net Income
$-55.2M
↓ 40.54%
Net Profit Margin
-96.11%
↑ 84.67%
Q2 FY23Q/Q Change
Revenue
$13.7M
↑ 31.99%
Net Income
$-15.6M
↓ 29.17%
Net Profit Margin
-113.79%
↑ 98.25%
Q3 FY23Q/Q Change
Revenue
$15.7M
↑ 14.14%
Net Income
$-9.0M
↓ 42.79%
Net Profit Margin
-57.03%
↑ 56.76%
Q4 FY23Q/Q Change
Revenue
$17.6M
↑ 11.93%
Net Income
$-8.5M
↓ 4.91%
Net Profit Margin
-48.45%
↑ 8.58%
Q1 FY24Q/Q Change
Revenue
$14.5M
↓ 17.43%
Net Income
$-11.7M
↑ 37.05%
Net Profit Margin
-80.42%
↓ 31.97%
Q2 FY24Q/Q Change
Revenue
$14.3M
↓ 1.7%
Net Income
$-16.5M
↑ 41.71%
Net Profit Margin
-115.94%
↓ 35.52%
Q3 FY24Q/Q Change
Revenue
$16.9M
↑ 18.32%
Net Income
$-12.7M
↓ 23.18%
Net Profit Margin
-75.28%
↑ 40.66%
FY18Y/Y Change
Profit
$59.7M
↑ 537.61%
FY19Y/Y Change
Profit
$-145.8M
↓ 344.46%
FY20Y/Y Change
Profit
$-189.1M
↑ 29.67%
FY21Y/Y Change
Profit
$48.0M
↓ 125.4%
FY22Y/Y Change
Profit
$44.8M
↓ 6.8%
FY23Y/Y Change
Profit
$16.8M
↓ 62.46%
Q2 FY23Q/Q Change
Profit
$12.4M
↑ 41.66%
Q3 FY23Q/Q Change
Profit
$14.4M
↑ 15.66%
Q4 FY23Q/Q Change
Profit
$13.2M
↓ 7.82%
Q1 FY24Q/Q Change
Profit
$13.0M
↓ 1.98%
Q2 FY24Q/Q Change
Profit
$4.3M
↓ 66.83%
Q3 FY24Q/Q Change
Profit
$16.9M
↑ 292.1%
FY18Y/Y Change
Operating Cash Flow
$-112.9M
↓ 43.86%
Investing Cash Flow
$176.7M
↓ 413.68%
Financing Cash Flow
$225.2M
↑ 13499.03%
FY19Y/Y Change
Operating Cash Flow
$-238.2M
↑ 111.04%
Investing Cash Flow
$-83.1M
↓ 147.0%
Financing Cash Flow
$1.3M
↓ 99.43%
FY20Y/Y Change
Operating Cash Flow
$-250.4M
↑ 5.12%
Investing Cash Flow
$10.7M
↓ 112.91%
Financing Cash Flow
$263.1M
↑ 20278.39%
FY21Y/Y Change
Operating Cash Flow
$-207.9M
↓ 16.99%
Investing Cash Flow
$124.5M
↑ 1061.22%
Financing Cash Flow
$91.9M
↓ 65.08%
FY22Y/Y Change
Operating Cash Flow
$-187.0M
↓ 10.04%
Investing Cash Flow
$1.2B
↑ 826.96%
Financing Cash Flow
$-758.8M
↓ 926.05%
Q2 FY23Q/Q Change
Operating Cash Flow
$-12.4M
↑ 10.83%
Investing Cash Flow
$11.0M
↓ 125.66%
Financing Cash Flow
$-80.7M
↑ 43.46%

Theravance Biopharma Technicals Summary

Sell

Neutral

Buy

Theravance Biopharma is currently in a neutral trading position according to technical analysis indicators.

Theravance Biopharma (TBPH) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Theravance Biopharma Inc logo
Theravance Biopharma Inc
3.08%
18.97%
11.21%
0.41%
-61.21%
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
Beone Medicines Ltd
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Theravance Biopharma Inc logo
Theravance Biopharma Inc
NA
NA
-0.05
0.15
-0.29
-0.07
NA
3.55
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
Beone Medicines Ltd
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Theravance Biopharma Inc logo
Theravance Biopharma Inc
Buy
$450.5M
-61.21%
NA
-87.63%
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
Beone Medicines Ltd
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
126.66%
NA
-12.37%

About Theravance Biopharma

Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States and Europe. It offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). The company's product includes Ampreloxetine, an investigational norepinephrine reuptake inhibitor that has completed Phase III study for neurogenic orthostatic hypotension; and TRELEGY for the treatment of COPD and asthma. It has licensing and collaboration agreements with Pfizer Inc. for its preclinical skin-selective pan-JAK inhibitor program, as well as Viatris Inc. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.
Organization
Theravance Biopharma
Employees
0
CEO
Mr. Rick E. Winningham M.B.A.
Industry
Health Technology

Management People of Theravance Biopharma

NameTitle
Mr. Rick E. Winningham M.B.A.
CEO & Director
Mr. Aziz Sawaf C.F.A.
Senior VP & CFO
Mr. Stuart Knight
Senior VP of IT&I and Chief Information Officer
Mr. Brett A. Grimaud Esq.
Senior VP, General Counsel & Secretary
Ms. Rhonda F. Farnum
Chief Business Officer and Senior VP of Commercial & Medical Affairs
Ms. Stacy L. Pryce
Senior VP & Chief Strategy Officer
Dr. Aine Miller Ph.D.
Senior VP of Development & Head of Ireland Office

Important FAQs about investing in TBPH Stock from India :

What is Theravance Biopharma share price today?

Theravance Biopharma share price today stands at $9.72, Open: $9.14 ; Previous Close: $9.10 ; High: $9.80 ; Low: $9.08 ; 52 Week High: $10.90 ; 52 Week Low: $7.44.

The stock opens at $9.14, after a previous close of $9.10. The stock reached a daily high of $9.80 and a low of $9.08, with a 52-week high of $10.90 and a 52-week low of $7.44.

Can Indians buy Theravance Biopharma shares?

Yes, Indians can invest in the Theravance Biopharma (TBPH) from India.

With INDmoney, you can buy Theravance Biopharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Theravance Biopharma at zero transaction cost.

How can I buy Theravance Biopharma shares from India?

It is very easy to buy Theravance Biopharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Theravance Biopharma (TBPH) be purchased?

Yes, you can buy fractional shares of Theravance Biopharma with INDmoney app.

What are the documents required to start investing in Theravance Biopharma stocks?

To start investing in Theravance Biopharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Theravance Biopharma Stock (TBPH)?

Today’s highest price of Theravance Biopharma (TBPH) is $9.80.

Today’s lowest price of Theravance Biopharma (TBPH) is $9.08.

What is today's market capitalisation of Theravance Biopharma?

Today's market capitalisation of Theravance Biopharma TBPH is 450.5M

What is the 52 Week High and Low Range of Theravance Biopharma Stock (TBPH)?

  • 52 Week High

    $10.90

  • 52 Week Low

    $7.44

What are the historical returns of Theravance Biopharma (TBPH)?

  • 1 Month Returns

    3.08%

  • 3 Months Returns

    18.97%

  • 1 Year Returns

    11.21%

  • 5 Years Returns

    -61.21%

Who is the Chief Executive Officer (CEO) of Theravance Biopharma ?

Mr. Rick E. Winningham M.B.A. is the current Chief Executive Officer (CEO) of Theravance Biopharma.